Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Palisade Bio, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 96
- +11 vs. Q4 2025
- Shares held
- 149.5M
- +15.7M (+11.8%) vs. Q4 2025
- Total value
- $261.7M
- −$52.7M (−16.8%) vs. Q4 2025
- New holders
- 31
- 30 more added
- Sold out
- 20
- 25 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PALI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $362.4M |
| Q1 2026 | 96 | $261.7M |
| Q4 2025 | 86 | $319.4M |
| Q3 2025 | 12 | $102.8K |
| Q2 2025 | 11 | $57.5K |
| Q1 2025 | 13 | $200.9K |
| Q4 2024 | 10 | $387.7K |
| Q3 2024 | 9 | $347.4K |
| Q2 2024 | 8 | $297.7K |
| Q1 2024 | 16 | $384.6K |
| Q4 2023 | 16 | $158.3K |
| Q3 2023 | 13 | $86.6K |
| Q2 2023 | 11 | $228.7K |
| Q1 2023 | 9 | $29.8K |
| Q4 2022 | 12 | $648.0K |
| Q3 2022 | 33 | $842.0K |
| Q2 2022 | 26 | $395.0K |
| Q1 2022 | 25 | $930.0K |
| Q4 2021 | 28 | $1.70M |
| Q3 2021 | 22 | $2.03M |
| Q2 2021 | 23 | $10.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Palisade Bio, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Superstring Capital Management LP | 0 | $0 | 0.00% | −367,103−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −240,586−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −212,659−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −211,441−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −204,448−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −166,049−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −106,636−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −102,108−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −39,480−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −14,041−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,870−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| SHP Wealth Management | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |